Safety and effectiveness of lu-177 dotatate prrt after regional hepatic radio or chemo embolization in patients with somatostatin expressing neuroendocrine tumors

被引:0
|
作者
Hamiditabar, Mohammadali [1 ]
Vahdati, Gelareh [1 ]
Amerinia, Reza [1 ]
Delpassand, Ebrahim [1 ]
机构
[1] Excel Diagnost & Nucl Oncol, Houston, TX USA
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
1436
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Evaluation of Kidney Dose in Neuroendocrine Tumors Patients after Peptide Receptor Radionuclide Therapy using 177Lu-DOTATATE
    Hidayati, N. R.
    Poon, A.
    Willowson, K.
    Eslick, E.
    Ryu, H.
    Bailey, D. L.
    ATOM INDONESIA, 2019, 45 (03) : 147 - 152
  • [32] NETTER-1 phase III: efficacy and safety results in patients with midgut neuroendocrine tumors treated with 177Lu-dotatate
    Strosberg, J.
    Wolin, E.
    Chasen, B.
    Kulke, M.
    Bushnell, D.
    Chaplin, M.
    Baum, R.
    Kunz, P.
    Hobday, T.
    Oberg, K.
    Sierra, M. Lopera
    Kwekkeboom, D.
    Ruszniewski, P.
    Krenning, E.
    Hendifar, A.
    ANNALS OF ONCOLOGY, 2016, 27 : 121 - 121
  • [33] NETTER-1 phase III: Efficacy and safety results in patients with midgut neuroendocrine tumors treated with 177Lu-DOTATATE
    Strosberg, Jonathan R.
    Wolin, Edward M.
    Chasen, Beth
    Kulke, Matthew H.
    Bushnell, David L.
    Caplin, Martyn E.
    Baum, Richard P.
    Hobday, Timothy J.
    Hendifar, Andrew Eugene
    Oberg, Kjell E.
    Sierra, Maribel Lopera
    Kwekkeboom, Dik J.
    Ruszniewski, Philippe B.
    Krenning, Eric
    Kunz, Pamela L.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [34] NETTER-1 Phase III in Patients with Midgut Neuroendocrine Tumors Treated with 177Lu-Dotatate: Efficacy and Safety Results
    Strosberg, Jonathan
    Wolin, Edward
    Chasen, Beth
    Kulke, Matthew
    Bushnell, David
    Caplin, Martin
    Baum, Richard
    Mittra, Erik
    Hobday, Timothy
    Hendifar, Andrew
    Oberg, Kjell
    Sierra, Maribel Lopera
    Kwekkeboom, Dik
    Ruszniewski, Philippe
    Krenning, Eric
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [36] NETTER-1 Phase III in Patients with Midgut Neuroendocrine Tumors Treated with 177Lu-Dotatate: Efficacy and Safety Results
    Strosberg, J.
    Wolin, E.
    Chasen, B.
    Kulke, M.
    Bushnell, D.
    Caplin, M.
    Baum, R. P.
    Kunz, P.
    Hobday, T.
    Hendifar, A.
    Oberg, K.
    Sierra, M. Lopera
    Kwekkeboom, D.
    Ruszniewski, P.
    Krenning, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S121 - S121
  • [37] NETTER-1 Phase III in Patients with Midgut Neuroendocrine Tumors Treated with 177Lu-DOTATATE: Efficacy and Safety Results
    Strosberg, J.
    Wolin, E.
    Chasen, B.
    Kulke, M.
    Bushnell, D.
    Caplin, M.
    Baum, R.
    Kunz, P.
    Hobday, T.
    Hendifar, A.
    Oberg, K.
    Sierra, Lopera M.
    Kwekkeboom, D.
    Ruszniewski, P.
    Krenning, E.
    NEUROENDOCRINOLOGY, 2016, 103 : 95 - 95
  • [38] Peptide Receptor Radionuclide Therapy With 177Lu-Octreotate in Patients With Somatostatin Receptor Expressing Neuroendocrine Tumors: Six Years' Assessment
    Hamiditabar, Mohammadali
    Ali, Muzammil
    Roys, Joseph
    Wolin, Edward M.
    O'Dorisio, Thomas M.
    Ranganathan, David
    Tworowska, Izabela
    Strosberg, Jonathan R.
    Delpassand, Ebrahim S.
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (06) : 436 - 443
  • [39] Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
    Mileva, Magdalena
    Marin, Gwennaelle
    Levillain, Hugo
    Artigas, Carlos
    Van Bogaert, Camille
    Marin, Clementine
    Danieli, Rachele
    Deleporte, Amelie
    Picchia, Simona
    Stathopoulos, Konstantinos
    Jungels, Christiane
    Vanderlinden, Bruno
    Paesmans, Marianne
    Ameye, Lieveke
    Critchi, Gabriela
    Taraji-Schiltz, Loubna
    Velghe, Chloe
    Wimana, Zena
    Bali, Maria
    Hendlisz, Alain
    Flamen, Patrick
    Karfis, Ioannis
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (02) : 236 - 244
  • [40] Broadening horizons with 225Ac-DOTATATE targeted alpha therapy for gastroenteropancreatic neuroendocrine tumour patients stable or refractory to 177Lu-DOTATATE PRRT: first clinical experience on the efficacy and safety
    Ballal, Sanjana
    Yadav, Madhav Prasad
    Bal, Chandrasekhar
    Sahoo, Ranjit Kumar
    Tripathi, Madhavi
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (04) : 934 - 946